Lerner Neil 4
4 · Compass Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Lerner Neil
Chief Accounting Officer
Transactions
- Award
Common Stock
2026-01-02$5.17/sh+62,500$323,125→ 382,500 total - Award
Stock Option (Right to Buy)
2026-01-02+435,000→ 435,000 totalExercise: $5.17Exp: 2036-01-02→ Common Stock (435,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first vesting on January 2, 2027.
- [F2]62,500 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.
- [F3]The options vest over 48 substantially equal monthly installments starting February 2, 2026.